Vimarsana
Biggest News Aggregation in the World

Page 15 - Consensus Estimates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Consensus Estimates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Consensus Estimates Today - Breaking & Trending Today

News Flash: Analysts Just Made A Substantial Upgrade To Their Byrna Technologies Inc. (NASDAQ:BYRN) Forecasts - Vimarsana News

News Flash: Analysts Just Made A Substantial Upgrade To Their Byrna Technologies Inc. (NASDAQ:BYRN) Forecasts

Celebrations may be in order for Byrna Technologies Inc. ( NASDAQ:BYRN ) shareholders, with the analysts delivering a...

Source: yahoo.com
Ansell Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - Vimarsana News

Ansell Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

The analysts might have been a bit too bullish on Ansell Limited ( ASX:ANN ), given that the company fell short of...

Source: yahoo.com
Moderna Stock Q4 Earnings Preview: RSV mRNA Vaccine Scrutiny, Diminishing Spikevax Revenue, FDA Approval In Focus - Moderna (NASDAQ:MRNA) - Vimarsana News

Moderna Stock Q4 Earnings Preview: RSV mRNA Vaccine Scrutiny, Diminishing Spikevax Revenue, FDA Approval In Focus - Moderna (NASDAQ:MRNA)

Moderna reports Q4 earnings on Feb. 22. Analysts expect $2.53B in revenue. Stock has faced challenges but potential for recovery with COVID-19 vaccine and FDA approval in 2024.

EV Maker Rivian Navigates Death Cross Ahead Of Q4 Earnings - Vimarsana News

EV Maker Rivian Navigates Death Cross Ahead Of Q4 Earnings

Electric vehicle (EV) manufacturer Rivian Automotive Inc (NASDAQ:RIVN) will report its fourth-quarter (Q4) earnings on Wednesday, Feb. 21. Wal...

EV Maker Rivian Navigates Death Cross Ahead Of Q4 Earnings - Rivian Automotive (NASDAQ:RIVN) - Vimarsana News

EV Maker Rivian Navigates Death Cross Ahead Of Q4 Earnings - Rivian Automotive (NASDAQ:RIVN)

Barclays recently downgraded Rivian to Equal Weight from Overweight and reduced the price target to $16 a share.